Research
May 21, 2020
UAMS Researcher to Use $991,000 to Improve Health of Arkansans with Food Insecurity and Type 2 Diabetes
FAYETTEVILLE – A University of Arkansas for Medical Sciences (UAMS) researcher recently received a $991,145 grant from the U.S. Department of Agriculture (USDA) to study the nutritional health of low-income individuals with type 2 diabetes. Christopher Long, Ph.D., an assistant professor in the Department of Psychiatry, will use the award from the USDA’s National Institute…
May 12, 2020
Arkansas INBRE Receives 5-Year Funding of $18.4 Million to Promote Biomedical Research Across Arkansas
Arkansas INBRE, which promotes biomedical research with programs for undergraduate students and faculty statewide, has seen its federal funding renewed for $18.4 million over the next five years. While the University of Arkansas for Medical Sciences (UAMS) is the lead institution, INBRE grants and programs have impacted nearly all colleges and universities in the state…
May 7, 2020
UAMS Receives FDA Authorization for Convalescent Plasma Use, Plus Partnerships for Statewide Access
The Food and Drug Administration has authorized the use of convalescent plasma in Arkansas as an experimental treatment for COVID-19 with the University of Arkansas for Medical Sciences (UAMS) as the expanded access treatment program sponsor. With the authorization, UAMS Medical Center is able to use the treatment now without applying for FDA approval for…
May 6, 2020
UAMS Radiation Oncologist Awarded $1.86 Million National Cancer Institute Grant
A five-year grant of more than $1.86 million from the National Cancer Institute (NCI) to the University of Arkansas for Medical Sciences (UAMS) will fund research aimed at reducing long-term neurological damage caused by a common cancer treatment regimen.
April 29, 2020
Cancer Biology Research Program Aims to Understand Basic Science of Tumor Development and Growth
The Cancer Biology program at the UAMS Winthrop P. Rockefeller Cancer Institute brings together investigators studying the basic biology of cancer at the molecular, cellular and in vivo levels. Program investigators use biochemical, genetic and other methodologies to study and understand the mechanisms of malignant transformation, tumor progression and tumor metastasis. Steven Post, Ph.D., professor in the…
April 28, 2020
Participation Surges as Trainings Supporting Educators and Children Shift Online
Helping a child identify emotions, enabling a home visitor to effectively work with a family, inspiring children to explore healthy foods, coaching a childcare facility through improving targeted goals — these are all things the early childhood education programs at UAMS did in person before March 2020. In a matter of weeks, the Research &…
April 24, 2020
UAMS Names Time-Sensitive COVID-19 Grant Awardees
The University of Arkansas for Medical Sciences (UAMS) Division of Research and Innovation today announced six recipients of its Time-Sensitive COVID-19 funding awards. The one-year grants of up to $50,000 each will enable the UAMS researchers and their collaborators to launch research projects that advance understanding of the COVID-19 pandemic, contribute to better clinical practices,…
April 16, 2020
New Repository Helps Faculty Stay on Tenure Track During COVID-19
Before Arkansas had its first COVID-19 case, the reality of the impending pandemic was already setting in for UAMS faculty as cancellations for scientific conferences worldwide were announced one after another like falling dominos. For scientists and academics, presenting to their peers at conferences is one of the main ways other than publications that they…
April 14, 2020
Reducing Cancer Therapy Side Effects One Goal of DNA Damage and Host Response Program
The DNA Damage and Host Response program at the UAMS Winthrop P. Rockefeller Cancer Institute studies DNA repair and genomic instability in cancer and normal tissues, as well as various biological mechanisms of and new interventions in adverse effects of cancer therapy. In particular, investigators are interested in genomic modifications involved in oncogenesis, resistance to…
April 8, 2020
UAMS Receives $1M Grant for Two Clinical Trials on Opioid Withdrawal in Infants
The University of Arkansas for Medical Sciences (UAMS), in collaboration with the Duke Clinical Research Institute, has received a $1 million federal grant for two clinical trials involving infants with neonatal opioid withdrawal syndrome (NOWS). The increase in maternal opioid use has resulted in a rise in the number of infants born with NOWS. The…
Next page